Back to search
FDAFDA · Food and drugs·Recall number D-0736-2018

Kalydeco 150 mg tablet blister, 28 days supply, Rx Only, 39183, NDC 51167-0200-01

Published May 16, 2018 · Recall initiated: April 3, 2018

Summary

FDA records drug Class II recall D-0736-2018, published May 16, 2018 and initiated April 3, 2018. Recalling firm: Kroger Specialty Pharmacy, Inc.; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Processing Controls.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Kroger Specialty Pharmacy, Inc.
Distributor
MS, LA, AR, IL, FL
Lot
All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Kalydeco 150 mg tablet blister, 28 days supply, Rx Only, 39183, NDC 51167-0200-01 recalled?

Yes. FDA published recall D-0736-2018 on May 16, 2018. Reported hazard: Lack of Processing Controls.

What should I do if I have this product?

Voluntary: Firm initiated · Letter